Pharmacy Bobanovic Vujnovic Pula
Pula, 52100, Croatia
NCT Number: NCT06889636
This study aims to assess and describe the impact of pharmaceutical care on identified drug-related problems (DRPs) in subjects using psycholeptics and psychoanaleptics in primary care, improving subjects' self-assessed quality of life (QoL)
The hypothesis of the study are:
1. Side-effects are the most common DRPs in subjects using psychotropic medicines in primary care, 2. Treatment effectiveness and safety affect the subjects´ QoL
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Pula, 52100, Croatia
The study objectives are to:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pharmacists' interventions were based on Medication Review and Medication Therapy Management evaluations of a subjects' pharmacotherapy to optimize medicine use, improve treatment outcomes and quality of life. The intervention involved the identification of drug-related problems and addressing these issues through pharmacist interventions. The intervention was based on information gathered from the subjects and a list of medicines in use.
Group B participants received pharmaceutical care based on common pharmacists' practice in Croatia during the dispensing of psychotropic drugs.
Time frame: Prior and after the pharmacists' intervention during three months period.
A short version of the World Health Organization's quality of life questionnaire (WHOQOL-BREF questionnaire) is being used to assess subjects' QoL. The scale range is from 0 to 100. A higher score number indicates better QoL.
Time frame: During period of three months.
To analyze the type of DRPs, validated Classification for Drug-Related Problems from the Pharmaceutical Care Network Europe Association, version 9.1 has been used. PCNE Classification for DRPs describes each type of DRP by unique code.
University of Rijeka
Other
Assessment of the Impact of Pharmaceutical Care on the Quality of Life in Conditions Related to Psychotropic Drug Use and Evaluation of the Intervention
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04893447
Adolescent, Adult
Boise, Idaho, United States
View Trial DetailsNCT01918774
Mental Disorders, Mental Health Services
Indianapolis, Indiana, United States
View Trial DetailsNCT06874439
Mental Health Care, Mental Health Services
Armentières, France
View Trial DetailsNCT03616990
Behavior, Chemically-Induced Disorders
Chicago, Illinois, United States
View Trial Details